Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00276172
Status:
COMPLETED
Last Update Posted:
2009-06-22
First Post:
2006-01-11
Brief Title:
Open-Label Natalizumab Safety Extension Study
Sponsor:
Organization:
Biogen